These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


540 related items for PubMed ID: 15653751

  • 1. Down-regulation of normal human T cell blast activation: roles of APO2L/TRAIL, FasL, and c- FLIP, Bim, or Bcl-x isoform expression.
    Bosque A, Pardo J, Martínez-Lorenzo MJ, Iturralde M, Marzo I, Piñeiro A, Alava MA, Naval J, Anel A.
    J Leukoc Biol; 2005 Apr; 77(4):568-78. PubMed ID: 15653751
    [Abstract] [Full Text] [Related]

  • 2. Human CD8+ T cell blasts are more sensitive than CD4+ T cell blasts to regulation by APO2L/TRAIL.
    Bosque A, Pardo J, Martínez-Lorenzo MJ, Lasierra P, Larrad L, Marzo I, Naval J, Anel A.
    Eur J Immunol; 2005 Jun; 35(6):1812-21. PubMed ID: 15884050
    [Abstract] [Full Text] [Related]

  • 3. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
    Ravi R, Bedi A.
    Cancer Res; 2002 Aug 01; 62(15):4180-5. PubMed ID: 12154014
    [Abstract] [Full Text] [Related]

  • 4. Differential secretion of Fas ligand- or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells.
    Monleón I, Martínez-Lorenzo MJ, Monteagudo L, Lasierra P, Taulés M, Iturralde M, Piñeiro A, Larrad L, Alava MA, Naval J, Anel A.
    J Immunol; 2001 Dec 15; 167(12):6736-44. PubMed ID: 11739488
    [Abstract] [Full Text] [Related]

  • 5. CD59 cross-linking induces secretion of APO2 ligand in overactivated human T cells.
    Monleón I, Martínez-Lorenzo MJ, Anel A, Lasierra P, Larrad L, Piñeiro A, Naval J, Alava MA.
    Eur J Immunol; 2000 Apr 15; 30(4):1078-87. PubMed ID: 10760796
    [Abstract] [Full Text] [Related]

  • 6. Regulation of expression of Bcl-2 protein family member Bim by T cell receptor triggering.
    Sandalova E, Wei CH, Masucci MG, Levitsky V.
    Proc Natl Acad Sci U S A; 2004 Mar 02; 101(9):3011-6. PubMed ID: 14970329
    [Abstract] [Full Text] [Related]

  • 7. Apoptosis by IL-2 deprivation in human CD8+ T cell blasts predominates over death receptor ligation, requires Bim expression and is associated with Mcl-1 loss.
    Bosque A, Marzo I, Naval J, Anel A.
    Mol Immunol; 2007 Feb 02; 44(6):1446-53. PubMed ID: 16806475
    [Abstract] [Full Text] [Related]

  • 8. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway.
    Siegmund D, Mauri D, Peters N, Juo P, Thome M, Reichwein M, Blenis J, Scheurich P, Tschopp J, Wajant H.
    J Biol Chem; 2001 Aug 31; 276(35):32585-90. PubMed ID: 11384965
    [Abstract] [Full Text] [Related]

  • 9. Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells.
    Martínez-Lorenzo MJ, Alava MA, Gamen S, Kim KJ, Chuntharapai A, Piñeiro A, Naval J, Anel A.
    Eur J Immunol; 1998 Sep 31; 28(9):2714-25. PubMed ID: 9754559
    [Abstract] [Full Text] [Related]

  • 10. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.
    Boussiotis VA, Lee BJ, Freeman GJ, Gribben JG, Nadler LM.
    J Immunol; 1997 Oct 01; 159(7):3156-67. PubMed ID: 9317113
    [Abstract] [Full Text] [Related]

  • 11. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.
    Moreno MB, Memon SA, Zacharchuk CM.
    J Immunol; 1996 Nov 01; 157(9):3845-9. PubMed ID: 8892614
    [Abstract] [Full Text] [Related]

  • 12. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention.
    Ahmad M, Shi Y.
    Oncogene; 2000 Jul 13; 19(30):3363-71. PubMed ID: 10918593
    [Abstract] [Full Text] [Related]

  • 13. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S, Meyer E, Debatin KM.
    Cancer Res; 2000 Jul 15; 60(14):3947-56. PubMed ID: 10919673
    [Abstract] [Full Text] [Related]

  • 14. A caspase-8-independent component in TRAIL/Apo-2L-induced cell death in human rhabdomyosarcoma cells.
    Petak I, Vernes R, Szucs KS, Anozie M, Izeradjene K, Douglas L, Tillman DM, Phillips DC, Houghton JA.
    Cell Death Differ; 2003 Jun 15; 10(6):729-39. PubMed ID: 12761581
    [Abstract] [Full Text] [Related]

  • 15. Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells.
    Poulaki V, Mitsiades CS, Kotoula V, Tseleni-Balafouta S, Ashkenazi A, Koutras DA, Mitsiades N.
    Am J Pathol; 2002 Aug 15; 161(2):643-54. PubMed ID: 12163389
    [Abstract] [Full Text] [Related]

  • 16. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
    Ray S, Almasan A.
    Cancer Res; 2003 Aug 01; 63(15):4713-23. PubMed ID: 12907654
    [Abstract] [Full Text] [Related]

  • 17. Cell cycle regulation by FasL and Apo2L/TRAIL in human T-cell blasts. Implications for autoimmune lymphoproliferative syndromes.
    Bosque A, Aguiló JI, del Rey M, Paz-Artal E, Allende LM, Naval J, Anel A.
    J Leukoc Biol; 2008 Aug 01; 84(2):488-98. PubMed ID: 18483205
    [Abstract] [Full Text] [Related]

  • 18. TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality.
    Corazza N, Jakob S, Schaer C, Frese S, Keogh A, Stroka D, Kassahn D, Torgler R, Mueller C, Schneider P, Brunner T.
    J Clin Invest; 2006 Sep 01; 116(9):2493-9. PubMed ID: 16955144
    [Abstract] [Full Text] [Related]

  • 19. Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity.
    Mirandola P, Ponti C, Gobbi G, Sponzilli I, Vaccarezza M, Cocco L, Zauli G, Secchiero P, Manzoli FA, Vitale M.
    Blood; 2004 Oct 15; 104(8):2418-24. PubMed ID: 15205263
    [Abstract] [Full Text] [Related]

  • 20. Responding naive T cells differ in their sensitivity to Fas engagement: early death of many T cells is compensated by costimulation of surviving T cells.
    Maksimow M, Santanen M, Jalkanen S, Hänninen A.
    Blood; 2003 May 15; 101(10):4022-8. PubMed ID: 12531803
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.